Top

Published in:

Open Access 01-08-2012 | Original Article

Assessing cancer patients' trust in their oncologist: development and validation of the Trust in Oncologist Scale (TiOS)

Authors: M. A. Hillen, C. C. E. Koning, J. W. Wilmink, J. H. G. Klinkenbijl, E. H. Eddes, B. L. Kallimanis-King, J. C. J. M. de Haes, E. M. A. Smets

Published in: Supportive Care in Cancer | Issue 8/2012

Abstract

Purpose

The aim of this study was to develop and validate the Trust in Oncologist Scale (TiOS), which aims to measure cancer patients' trust in their oncologist. Structure, reliability and validity were examined.

Methods

Construction of the TiOS was based on a multidimensional theoretical framework. Cancer patients were surveyed within a week after their consultation. Trust, satisfaction, trust in health care, self-reported health and background variables were assessed. Dimensionality, internal consistency, test–retest reliability and construct validity were investigated.

Results

Data of 423 patients were included (response rate = 65%). After item reduction, the TiOS included 18 items. Trust scores were high. Exploratory factor analysis suggested one-dimensionality. Confirmatory factor analysis nevertheless indicated a reasonable fit of our four-dimensional theoretical model, distinguishing competence, fidelity, honesty and caring. Internal consistency and test–retest reliabilities were high. Good construct validity was indicated by moderate correlations of trust (TiOS) with satisfaction, trust in health care, willingness to recommend and number of consultations with the oncologist. Exploratory analyses suggested significant correlations of trust with ethnicity and age.

Conclusions

The TiOS reliably and validly assesses cancer patients' trust in their oncologist. The questionnaire can be employed in both clinical practice and future research of cancer patients' trust.

Readers interested in all candidate items, please contact the authors.

Mechanic D, Meyer S (2000) Concepts of trust among patients with serious illness. Soc Sci Med 51(5):657–668PubMedCrossRef

Goudge J, Gilson L (2005) How can trust be investigated? Drawing lessons from past experience. Soc Sci Med 61:1439–1451PubMedCrossRef

McKinstry B, Ashcroft RE, Car J, Freeman GK, Sheikh A (2006) Interventions for improving patients' trust in doctors and groups of doctors. Cochrane Database Syst Rev 3: Art. No.: CD004134

Hall MA, Dugan E, Zheng BY, Mishra AK (2001) Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q 79(4):613–639PubMedCrossRef

Baier A (1986) Trust and antitrust. Ethics 96:231–260CrossRef

Goold SD (2002) Trust, distrust and trustworthiness. J Gen Intern Med 17(1):79–81PubMedCrossRef

Pearson SD, Raeke LH (2000) Patients' trust in physicians: many theories, few measures, and little data. J Gen Intern Med 15(7):509–513PubMedCrossRef

Seetharamu N, Iqbal U, Weiner JS (2007) Determinants of trust in the patient-oncologist relationship. Palliat Support Care 5(4):405–409PubMedCrossRef

Thom DH, Ribisl KM, Stewart AL, Luke DA (1999) Further validation and reliability testing of the Trust in Physician Scale. Med Care 37(5):510–517PubMedCrossRef

10.

Hall MA, Zheng BY, Dugan E et al (2002) Measuring patients' trust in their primary care providers. Med Care Res Rev 59(3):293–318PubMedCrossRef

11.

Trachtenberg F, Dugan E, Hall MA (2005) How patients' trust relates to their involvement in medical care. J Fam Pract 54(4):344–352PubMed

12.

Safran DG, Taira DA, Rogers WH et al (1998) Linking primary care performance to outcomes of care. J Fam Pract 47(3):213–220PubMed

13.

O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J (2004) The role of trust in use of preventive services among low-income African-American women. Prev Med 38(6):777–785PubMedCrossRef

14.

Balkrishnan R, Dugan E, Camacho FT, Hall MA (2003) Trust and satisfaction with physicians, insurers, and the medical profession. Med Care 41(9):1058–1064PubMedCrossRef

15.

Hillen MA, de Haes HC, Smets EM (2011) Cancer patients' trust in their physician—a review. Psychooncology 20:227–241PubMedCrossRef

16.

Anderson AA, Dedrick FD (1990) Development of the trust in physician scale: a measure to assess interpersonal trust in patient–physician relationships. Psychol Rep 67:1091–1100PubMed

17.

Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD (1998) The relationship between method of physician payment and patient trust. JAMA 280(19):1708–1714PubMedCrossRef

18.

Hillen MA, Onderwater AT, Van Zwieten MCB, de Haes JC, Smets EM (2011) Disentangling cancer patients’ trust in their oncologist: a qualitative study. Psychooncology (in press)

19.

Wolf MH, Putnam SM, James SA, Stiles WB (1978) The medical interview satisfaction scale: development of a scale to measure patient perceptions of physician behavior. J Behav Med 1(4):391–401PubMedCrossRef

20.

Safran DG, Kosinski M, Tarlov AR et al (1998) The primary care assessment survey—tests of data quality and measurement performance. Med Care 36(5):728–739PubMedCrossRef

21.

Oosterveld P, Vorst HCM (1998) Constructie van meetinstrumenten. Testleer en testconstructie, In: Van Den Brink WP and Mellenbergh GJ (Eds), Amsterdam, Boom pp 305–337

22.

Willis G (1999) Cognitive Interviewing. A ‘How To’ Guide. Research Triangle Park, NC, Research Triangle Institute

23.

Tabachnick BG, Fidell LS (2001) Using multivariate statistics, 4th edn. Boston, Allyn and Bacon

24.

Ong LML, Visser MRM, Lammes FB, de Haes JCJM (2000) Doctor-patient communication and cancer patients' quality of life and satisfaction. Patient Educ Couns 41:145–156PubMedCrossRef

25.

Gandek B, Ware JE, Aaronson NK et al (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. J Clin Epidemiol 51(11):1171–1178PubMedCrossRef

26.

Ware JE, Kosinski M, Keller SD (1996) A 12-item Short-Form Health Survey: construction of scales and preliminary test of reliability and validity. Med Care 34:220–226PubMedCrossRef

27.

Tabachnick BG, Fidell LS (2000) Cleaning up your act: screening data prior to analysis. In Using multivariate statistics, 4th ed. Allyn and Bacon pp 56–110

28.

Carpenter WR, Godley PA, Clark JA et al (2009) Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer 115(21):5048–5059PubMedCrossRef

29.

Marshall GN, Hays RD, Sherbourne CD, Wells KD (1993) The structure of patient satisfaction with outpatient medical care. Psychol Assess 5(4):477–483CrossRef

30.

Doescher MP, Saver BG, Franks P, Fiscella K (2000) Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med 9:1156–1163PubMedCrossRef

31.

Salmon P, Young B (2009) Dependence and caring in clinical communication: the relevance of attachment and other theories. Patient Educ Couns 74(3):331–338PubMedCrossRef

32.

Berrios-Rivera JP, Street RL, Popa-Lisseanu MGG et al (2006) Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 55(3):385–393PubMedCrossRef

33.

Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR (2003) Race and trust in the health care system. Public Health Rep 118:358–365PubMed

34.

Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J (2006) Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol 24(6):904–909PubMedCrossRef

35.

De Houwer J, Teige-Mocigemba S, Spruyt A, Moors A (2009) Implicit measures: a normative analysis and review. Psychol Bull 135(3):347–368PubMedCrossRef

36.

Epner DE, Ravi V, Baile WF (2010) “When patients and families feel abandoned”. Support Care Cancer doi:10.1007/s00520-010-1007-6

Title: Assessing cancer patients' trust in their oncologist: development and validation of the Trust in Oncologist Scale (TiOS)
Authors: M. A. Hillen
C. C. E. Koning
J. W. Wilmink
J. H. G. Klinkenbijl
E. H. Eddes
B. L. Kallimanis-King
J. C. J. M. de Haes
E. M. A. Smets
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 8/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-011-1276-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2012

Motorcycles and breast cancer: The influence of peer support and challenge on distress and posttraumatic growth

Self-care and end of life care—patients’ and carers’ experience a qualitative study utilising serial triangulated interviews

Development of a knowledge assessment tool for dermatotoxicity caused by inhibitors of epidermal growth factor receptor

Emergency department visits for symptoms experienced by oncology patients: a systematic review

Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation

Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer